Dynamic Cell Therapies is developing controllable CAR T cells to address difficult-to-treat cancers. Our platform technology of dynamic control of engineered T cells will improve the safety, efficacy, and durability of CAR T cell therapies. This system will have immediate applications in hematological cancers, with future approaches in solid tumors and autoimmune diseases.
Location: United States, Massachusetts, Boston
Employees: 11-50
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | Cobro Vent... | cobroventu... |